Subcutaneous fat necrosis of the newborn

Neutrophil-rich subcutaneous fat necrosis of the newborn: A potential mimic of infection

BACKGROUND

The inflammatory infiltrate seen in biopsy specimens obtained from patients with subcutaneous fat necrosis of the newborn (SCFN) has classically been described as consisting mostly of histiocytes. However, we encountered patients with SCFN whose biopsy specimens revealed mostly neutrophils, prompting infection to be an initial consideration.

OBJECTIVES

We sought to describe cases of SCFN in which neutrophils formed the majority of the infiltrate at our institution and in the literature.

METHODS

We performed a retrospective analysis of patients with SCFN reported at our institution and a literature review of SCFN.

RESULTS

Thirteen cases of SCFN were identified at our institution. In 2 of 13 cases, neutrophils composed >75% of the inflammatory infiltrate, and both lesions were 1 day old. From the literature review, neutrophils were mentioned as a component of the infiltrate in 10 of 124 cases, but in none were neutrophils described as forming the majority of the infiltrate.

LIMITATIONS

This study is limited by its retrospective nature and small sample size.

CONCLUSIONS

Neutrophils can comprise most of the inflammatory cells in patients with SCFN, especially early in the course of the disease. This variant of SCFN can be easily mistaken for infection.

Subcutaneous fat necrosis as a complication of therapeutic hypothermia in a term neonate

Subcutaneous fat necrosis of the newborn (SCFN) is a benign self-limited disorder commonly associated with hypothermia and perinatal asphyxia. SCFN secondary to therapeutic whole body hypothermia has rarely been reported. With increasing use of cooling for moderate to severe hypoxic ischemic encephalopathy (HIE), clinicians should recognize this potential complication.

[Subcutaneous fat necrosis in the newborn: a risk for severe hypercalcemia]

Hypercalcemia associated with subcutaneous fat necrosis (SCN) is a well known but rare event in the newborn. A newborn infant with a history of SCN was admitted because of anorexia, adynamia, polyuria and polydipsia at 6 weeks of age. Serum calcium was markedly increased on admission, while it was normal on the first day of life. Evolution was favourable after treatment including isotonic saline solution, furosemide, corticosteroids, calcitonin and a low calcium and vitamin D diet. Hypercalcemia was severe enough to potentially induces fatal complications in this case. Neonates who develop skin lesions consistent with SCN should be followed-up for possible onset of hypercalcemia and treated in due time. The treatment of hypercalcemia in SCN is reviewed.